Merit Medical Systems, Inc. (MMSI) COO Ronald Frost Sells 4,743 Shares

Merit Medical Systems, Inc. (NASDAQ:MMSI) COO Ronald Frost sold 4,743 shares of Merit Medical Systems stock in a transaction dated Friday, November 16th. The shares were sold at an average price of $61.30, for a total value of $290,745.90. Following the completion of the sale, the chief operating officer now directly owns 4,743 shares in the company, valued at approximately $290,745.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Ronald Frost also recently made the following trade(s):

  • On Wednesday, November 7th, Ronald Frost sold 5,257 shares of Merit Medical Systems stock. The shares were sold at an average price of $61.31, for a total value of $322,306.67.

Shares of NASDAQ MMSI opened at $58.35 on Friday. The company has a market cap of $3.20 billion, a price-to-earnings ratio of 45.59, a price-to-earnings-growth ratio of 2.70 and a beta of 1.19. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.47 and a current ratio of 2.77. Merit Medical Systems, Inc. has a twelve month low of $41.25 and a twelve month high of $66.34.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Thursday, October 25th. The medical instruments supplier reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.42 by $0.05. The firm had revenue of $221.66 million for the quarter, compared to the consensus estimate of $217.62 million. Merit Medical Systems had a return on equity of 10.86% and a net margin of 4.72%. On average, analysts anticipate that Merit Medical Systems, Inc. will post 1.66 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Legal & General Group Plc boosted its holdings in shares of Merit Medical Systems by 15.9% during the third quarter. Legal & General Group Plc now owns 127,157 shares of the medical instruments supplier’s stock worth $7,774,000 after acquiring an additional 17,489 shares during the period. Sawgrass Asset Management LLC boosted its holdings in shares of Merit Medical Systems by 13.4% during the third quarter. Sawgrass Asset Management LLC now owns 35,840 shares of the medical instruments supplier’s stock worth $2,202,000 after acquiring an additional 4,245 shares during the period. Teachers Advisors LLC boosted its holdings in shares of Merit Medical Systems by 13.7% during the third quarter. Teachers Advisors LLC now owns 137,761 shares of the medical instruments supplier’s stock worth $8,465,000 after acquiring an additional 16,577 shares during the period. Macquarie Group Ltd. boosted its holdings in shares of Merit Medical Systems by 2.2% during the third quarter. Macquarie Group Ltd. now owns 1,103,149 shares of the medical instruments supplier’s stock worth $67,789,000 after acquiring an additional 24,083 shares during the period. Finally, Thrivent Financial for Lutherans boosted its holdings in shares of Merit Medical Systems by 380.3% during the third quarter. Thrivent Financial for Lutherans now owns 166,105 shares of the medical instruments supplier’s stock worth $10,207,000 after acquiring an additional 131,522 shares during the period. 88.59% of the stock is currently owned by hedge funds and other institutional investors.

A number of analysts recently issued reports on the company. Zacks Investment Research raised Merit Medical Systems from a “sell” rating to a “hold” rating in a research report on Thursday, July 26th. Barrington Research lifted their target price on Merit Medical Systems to $69.00 and gave the company an “outperform” rating in a research report on Tuesday, October 2nd. Piper Jaffray Companies boosted their price target on Merit Medical Systems from $58.00 to $72.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 2nd. Bank of America downgraded Merit Medical Systems from a “buy” rating to an “underperform” rating and set a $64.00 price target on the stock. in a research report on Tuesday, August 7th. Finally, Needham & Company LLC boosted their price target on Merit Medical Systems from $67.00 to $73.00 and gave the stock a “buy” rating in a research report on Tuesday, October 2nd. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and two have issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $68.10.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by WKRB News and is the sole property of of WKRB News. If you are reading this piece of content on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The legal version of this piece of content can be read at https://www.wkrb13.com/2018/11/23/merit-medical-systems-inc-mmsi-coo-ronald-frost-sells-4743-shares.html.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management.

Further Reading: What is a bull market?

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply